Literature DB >> 1697791

In vivo significance of T cells in the development of Coxsackievirus B3 myocarditis in mice. Immature but antigen-specific T cells aggravate cardiac injury.

C Kishimoto1, W H Abelmann.   

Abstract

Acute myocardial damage similar to that seen in human myocarditis occurs in BALB/c mice after infection with coxsackievirus B3 (CB3) or encephalomyocarditis virus (EMC). To investigate the role of antigen-specific T cells in the pathogenesis of this disorder, we compared CB3 disease expression in T cell-deficient, athymic nude (nu/nu) mice, in heterozygote (nu/+) mice with normal T cell function, and in nu/nu mice reconstituted with spleen cells from CB3- or EMC-infected nu/+ mice. Acute myocarditis occurred in both nu/nu and nu/+ mice. Severe myocarditis, however, developed only in nu/+ and nu/nu mice reconstituted with CB3-sensitized T cells, but not in those reconstituted with EMC-sensitized T cells. Myocardial virus titer and serum anti-CB3 antibody production were similar in nu/+ and nu/nu groups. Additionally, the presence of Thy 1.2 (pan T), Ly 1 (precursor of other T cell subsets), and Ly 2 (suppressor/cytotoxic T) positive cells was demonstrated in the myocardium in nu/+ and nu/nu mice reconstituted with CB3-sensitized T cells, but not with T cells sensitized by another virus, EMC. These results indicate that immature but antigen-specific T cells play a role in the pathogenesis of ongoing myocarditis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1697791     DOI: 10.1161/01.res.67.3.589

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  13 in total

1.  Enhanced production of macrophage inflammatory protein 2 (MIP-2) by in vitro and in vivo infections with encephalomyocarditis virus and modulation of myocarditis with an antibody against MIP-2.

Authors:  C Kishimoto; H Kawamata; S Sakai; H Shinohara; H Ochiai
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

Review 2.  T-cell recruitment to the heart: friendly guests or unwelcome visitors?

Authors:  Robert M Blanton; Francisco J Carrillo-Salinas; Pilar Alcaide
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-05-10       Impact factor: 4.733

3.  Coxsackievirus B3-induced myocarditis: perforin exacerbates disease, but plays no detectable role in virus clearance.

Authors:  J R Gebhard; C M Perry; S Harkins; T Lane; I Mena; V C Asensio; I L Campbell; J L Whitton
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

4.  In vivo ablation of type I interferon receptor from cardiomyocytes delays coxsackieviral clearance and accelerates myocardial disease.

Authors:  Nadine Althof; Stephanie Harkins; Christopher C Kemball; Claudia T Flynn; Mehrdad Alirezaei; J Lindsay Whitton
Journal:  J Virol       Date:  2014-02-26       Impact factor: 5.103

5.  Failure of treatment with interleukin-2 receptor-specific monoclonal antibody in acute coxsackievirus B3 myocarditis in mice.

Authors:  C Kishimoto; Y Hiraoka; H Takada; M Kurokawa; H Ochiai
Journal:  Heart Vessels       Date:  1997       Impact factor: 2.037

6.  Lymphocytes protect against and are not required for reovirus-induced myocarditis.

Authors:  B Sherry; X Y Li; K L Tyler; J M Cullen; H W Virgin
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

7.  The effects of lobenzarit disodium, a novel immunomodulator, upon murine coxsackievirus B3 myocarditis.

Authors:  H Takada; C Kishimoto; Y Kuroki; I Matsushita; Y Hiraoka; M Kurokawa; H Ochiai; S Sasayama
Journal:  Heart Vessels       Date:  1993       Impact factor: 2.037

8.  Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice.

Authors:  B S Graham; L A Bunton; P F Wright; D T Karzon
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

9.  Amyocarditic coxsackievirus B3 causes myocarditis in immunocompromised mice.

Authors:  Hitoshi Takada; Chiharu Kishimoto; Masahiko Kurokawa; Yuji Hiraoka
Journal:  Exp Clin Cardiol       Date:  2003

10.  Nucleotide differences of coxsackievirus B3 and chronic myocarditis.

Authors:  Chiharu Kishimoto; Nami Takamatsu; Hiroshi Ochiai; Kagemasa Kuribayashi
Journal:  Heart Vessels       Date:  2014-02-04       Impact factor: 2.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.